Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pancreatic Adenocarcinoma × Interleukin 1 Receptor Antagonist Protein × 1 year × Clear all

Sponsor

Conditions

Lymphoma, B-Cell 2 Cytokine Release Syndrome 2 Burkitt Lymphoma 2 Pancreatic Neoplasms 1 Neurotoxicity Syndromes 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Disease Progression 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 4 Taxes 2 Radiotherapy, Intensity-Modulated 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 tocilizumab 1 selicrelumab 1 niraparib 1 durvalumab 1 cobimetinib 1 atezolizumab 1 Tiragolumab 1 Radiotherapy 1 Panitumumab 1 PEGPH20 1 Oxaliplatin 1 Optical Imaging 1 Nivolumab 1 Metformin 1 Losartan 1 Leucovorin 1 Irinotecan 1 Ipilimumab 1 Fluorouracil 1 Blood Specimen Collection 1 Bevacizumab 1 Anesthesia, General 1 Anesthesia 1 4-fluorobenzoyl-TN-14003 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡